Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Prosensa jumps 30% after data from Phase 2 study of DMD drug
Prosensa jumps 30% after data from Phase 2 study of DMD drug
Prosensa jumps 30% after data from Phase 2 study of DMD drug
Submitted by
admin
on March 18, 2014 - 9:01am
Source:
The Fly on the Wall
News Tags:
Prosensa
Duchenne Muscular Dystrophy
drisapersen
Sarepta Therapeutics
Headline:
Prosensa jumps 30% after data from Phase 2 study of DMD drug
Do Not Allow Advertisers to Use My Personal information
